Paul Lizzul
2022
In 2022, Paul Lizzul earned a total compensation of $3.8M as Chief Medical Officer at ANAPTYSBIO.
Compensation breakdown
Non-Equity Incentive Plan | $174,544 |
---|---|
Option Awards | $2,872,730 |
Salary | $471,740 |
Stock Awards | $283,440 |
Other | $10,074 |
Total | $3,812,528 |
Lizzul received $2.9M in option awards, accounting for 75% of the total pay in 2022.
Lizzul also received $174.5K in non-equity incentive plan, $471.7K in salary, $283.4K in stock awards and $10.1K in other compensation.
Rankings
In 2022, Paul Lizzul's compensation ranked 923rd out of 5,751 executives tracked by ExecPay. In other words, Lizzul earned more than 84.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 923 | 84th |
Manufacturing | 424 | 87th |
Chemicals And Allied Products | 153 | 89th |
Drugs | 139 | 90th |
Pharmaceutical Preparations | 103 | 89th |
Lizzul's colleagues
We found two more compensation records of executives who worked with Paul Lizzul at ANAPTYSBIO in 2022.